# Commercial Lidocaine Patch as a Treatment for Ear-ringing

> **NCT02088866** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 30 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** Transdermal Lidocaine

## Key facts

- **NCT ID:** NCT02088866
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02088866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02088866, "Commercial Lidocaine Patch as a Treatment for Ear-ringing". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02088866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*